-
2
-
-
0032998479
-
Does academic achievement in children with epilepsy change over time?
-
DOI 10.1017/S0012162299001024
-
Austin JK, Huberty TJ, Huster GA, Dunn DW. Does academic achievement in children with epilepsy change over time? Dev. Med. Child Neurol. 41(7), 473-479 (1999 (Pubitemid 29322488)
-
(1999)
Developmental Medicine and Child Neurology
, vol.41
, Issue.7
, pp. 473-479
-
-
Austin, J.K.1
Huberty, T.J.2
Huster, G.A.3
Dunn, D.W.4
-
3
-
-
59149102224
-
Antiepileptic drug-Induced cognitive adverse effects: Potential mechanisms and contributing factors
-
Mula M, Trimble MR. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs 23(2), 121-137 (2009
-
(2009)
CNS Drugs
, vol.23
, Issue.2
, pp. 121-137
-
-
Mula, M.1
Trimble, M.R.2
-
4
-
-
36849006900
-
Neuropsychological and behavioral effects of antiepilepsy drugs
-
DOI 10.1007/s11065-007-9043-9, Special Issue Neuropsychology of Epilepsy: Current Trends
-
Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol. Rev. 17(4), 413-425 (2007 (Pubitemid 350231552)
-
(2007)
Neuropsychology Review
, vol.17
, Issue.4
, pp. 413-425
-
-
Loring, D.W.1
Marino, S.2
Meador, K.J.3
-
5
-
-
72949114263
-
Cognition across the lifespan: Antiepileptic drugs, epilepsy, or both
-
Hermann B, Meador KJ, Gaillard WD, Cramer JA. Cognition across the lifespan: antiepileptic drugs, epilepsy, or both? Epilepsy Behav. 17(1), 1-5 (2010
-
(2010)
Epilepsy Behav.
, vol.17
, Issue.1
, pp. 1-5
-
-
Hermann, B.1
Meador, K.J.2
Gaillard, W.D.3
Cramer, J.A.4
-
6
-
-
0026775168
-
Cognitive function - Victim of disease or hostage to treatment
-
Dreifuss FE. Cognitive function - victim of disease or hostage to treatment? Epilepsia 33(Suppl. 1), S7-12 (1992
-
(1992)
Epilepsia
, vol.33
, Issue.SUPPL. 1
-
-
Dreifuss, F.E.1
-
7
-
-
10744230559
-
A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events
-
DOI 10.1016/j.yebeh.2003.07.007
-
Kanner AM, Wuu J, Faught E, Tatum WO 4th, Fix A, French JA; PADS Investigators. A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav. 4(5), 548-552 (2003 (Pubitemid 37407613)
-
(2003)
Epilepsy and Behavior
, vol.4
, Issue.5
, pp. 548-552
-
-
Kanner, A.M.1
Wuu, J.2
Faught, E.3
Tatum IV, W.O.4
Fix, A.5
French, J.A.6
Bourgeois, B.B.E.7
Brown, L.8
Burgerman, R.9
Erba, G.10
Faught, E.11
Harden, C.12
Jacobson, M.13
Liporace, J.14
Montouris, G.15
Morris, G.16
Privitera, M.17
Rosenfield, W.18
Vossler, D.19
-
8
-
-
33846234734
-
Lacosamide
-
DOI 10.1016/j.nurt.2006.10.002, PII S1933721306001759, New Antiepileptic Drugs: Discovery, Development, and Update
-
Doty P, Rudd GD, Stoehr T, Thomas D. Lacosamide. Neurotherapeutics 4(1), 145-148 (2007 (Pubitemid 46107317)
-
(2007)
Neurotherapeutics
, vol.4
, Issue.1
, pp. 145-148
-
-
Doty, P.1
Rudd, G.D.2
Stoehr, T.3
Thomas, D.4
-
9
-
-
61849088333
-
SP755 study group adjunctive lacosamide for partial-Onset seizures: Efficacy and safety results from a randomized controlled trial
-
Halász P, Kälviäinen R, Mazurkiewicz- Beldzinska M et al.; SP755 Study Group. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 50(3), 443-453 (2009
-
(2009)
Epilepsia
, vol.50
, Issue.3
, pp. 443-453
-
-
Halász, P.1
Kälviäinen, R.2
Mazurkiewicz-Beldzinska, M.3
-
10
-
-
40849086321
-
Lacosamide: An investigational drug for adjunctive treatment of partial-onset seizures
-
DOI 10.1358/dot.2008.44.1.1178468
-
Ben-Menachem E. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures. Drugs Today 44(1), 35-40 (2008 (Pubitemid 351397411)
-
(2008)
Drugs of Today
, vol.44
, Issue.1
, pp. 35-40
-
-
Ben-Menachem, E.1
-
11
-
-
77953033494
-
Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial
-
SP754 Study Group
-
Chung S, Sperling MR, Biton V et al.; SP754 Study Group. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 51(6), 958-967 (2010
-
(2010)
Epilepsia
, vol.51
, Issue.6
, pp. 958-967
-
-
Chung, S.1
Sperling, M.R.2
Biton, V.3
-
12
-
-
72049099610
-
Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: Relationship to antiepileptic property
-
Higgins GA, Breysse N, Undzys E et al. Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: relationship to antiepileptic property. Psychopharmacology (Berl.) 207(4), 513-527 (2010
-
(2010)
Psychopharmacology (Berl.)
, vol.207
, Issue.4
, pp. 513-527
-
-
Higgins, G.A.1
Breysse, N.2
Undzys, E.3
-
13
-
-
34548358604
-
Rufinamide
-
DOI 10.1358/dot.2007.43.7.1067344
-
Heaney D, Walker MC. Rufinamide. Drugs Today 43(7), 455-460 (2007 (Pubitemid 47344922)
-
(2007)
Drugs of Today
, vol.43
, Issue.7
, pp. 455-460
-
-
Heaney, D.1
Walker, M.C.2
-
14
-
-
44949184519
-
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome
-
Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 70(21), 1950-1958 (2008
-
(2008)
Neurology
, vol.70
, Issue.21
, pp. 1950-1958
-
-
Glauser, T.1
Kluger, G.2
Sachdeo, R.3
Krauss, G.4
Perdomo, C.5
Arroyo, S.6
-
15
-
-
80052566407
-
Rufinamide from clinical trials to clinical practice in the United States and Europe
-
Resnick T, Arzimanoglou A, Brown LW et al. Rufinamide from clinical trials to clinical practice in the United States and Europe. Epileptic Disord. 13(Suppl. 1), S27-S43 (2011
-
(2011)
Epileptic Disord.
, vol.13
, Issue.SUPPL. 1
-
-
Resnick, T.1
Arzimanoglou, A.2
Brown, L.W.3
-
16
-
-
33746111455
-
The effect of the new antiepileptic drug rufinamide on cognitive functions
-
DOI 10.1111/j.1528-1167.2006.00589.x
-
Aldenkamp AP, Alpherts WC. The effect of the new antiepileptic drug rufinamide on cognitive functions. Epilepsia 47(7), 1153-1159 (2006 (Pubitemid 44086750)
-
(2006)
Epilepsia
, vol.47
, Issue.7
, pp. 1153-1159
-
-
Aldenkamp, A.P.1
Alpherts, W.C.J.2
-
17
-
-
79955592696
-
Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
-
RESTORE 1/Study 301 Investigators
-
French JA, Abou-Khalil BW, Leroy RF et al.; RESTORE 1/Study 301 Investigators. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology 76(18), 1555-1563 (2011
-
(2011)
Neurology
, vol.76
, Issue.18
, pp. 1555-1563
-
-
French, J.A.1
Abou-Khalil, B.W.2
Leroy, R.F.3
-
18
-
-
78649984382
-
Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy
-
RESTORE 2 Study Group
-
Brodie MJ, Lerche H, Gil-Nagel A et al.; RESTORE 2 Study Group. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology 75(20), 1817-1824 (2010
-
(2010)
Neurology
, vol.75
, Issue.20
, pp. 1817-1824
-
-
Brodie, M.J.1
Lerche, H.2
Gil-Nagel, A.3
-
19
-
-
34247252905
-
Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures
-
DOI 10.1212/01.wnl.0000259034.45049.00, PII 0000611420070410000009
-
Porter RJ, Partiot A, Sachdeo R, Nohria V, Alves WM; 205 Study Group. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 68(15), 1197-1204 (2007 (Pubitemid 46608467)
-
(2007)
Neurology
, vol.68
, Issue.15
, pp. 1197-1204
-
-
Porter, R.J.1
Partiot, A.2
Sachdeo, R.3
Nohria, V.4
Alves, W.M.5
-
20
-
-
70649099046
-
Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder
-
Dencker D, Husum H. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder. Behav. Brain Res. 207(1), 78-83 (2010
-
(2010)
Behav. Brain Res.
, vol.207
, Issue.1
, pp. 78-83
-
-
Dencker, D.1
Husum, H.2
-
21
-
-
37049038680
-
Effect of the new antiepileptic drug retigabine in a rodent model of mania
-
DOI 10.1016/j.yebeh.2007.09.023, PII S1525505007003290
-
Dencker D, Dias R, Pedersen ML, Husum H. Effect of the new antiepileptic drug retigabine in a rodent model of mania. Epilepsy Behav. 12(1), 49-53 (2008 (Pubitemid 350246381)
-
(2008)
Epilepsy and Behavior
, vol.12
, Issue.1
, pp. 49-53
-
-
Dencker, D.1
Dias, R.2
Pedersen, M.L.3
Husum, H.4
-
22
-
-
23044477292
-
v7 channels
-
DOI 10.1124/jpet.105.083923
-
Korsgaard MP, Hartz BP, Brown WD, Ahring PK, Strøbaek D, Mirza NR. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. J. Pharmacol. Exp. Ther. 314(1), 282-292 (2005 (Pubitemid 41058265)
-
(2005)
Journal of Pharmacology and Experimental Therapeutics
, vol.314
, Issue.1
, pp. 282-292
-
-
Korsgaard, M.P.G.1
Hartz, B.P.2
Brown, W.D.3
Ahring, P.K.4
Strobaek, D.5
Mirza, N.R.6
-
23
-
-
33745251005
-
New antiepileptic drugs that are second generation to existing antiepileptic drugs
-
Bialer M. New antiepileptic drugs that are second generation to existing antiepileptic drugs. Expert Opin. Investig. Drugs 15(6), 637-647 (2006
-
(2006)
Expert Opin. Investig. Drugs
, vol.15
, Issue.6
, pp. 637-647
-
-
Bialer, M.1
-
24
-
-
57849141134
-
Progress report on new antiepileptic drugs: A summary of the ninth eilat conference eilat ix
-
Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res. 83(1), 1-43 (2009
-
(2009)
Epilepsy Res.
, vol.83
, Issue.1
, pp. 1-43
-
-
Bialer, M.1
Johannessen, S.I.2
Levy, R.H.3
Perucca, E.4
Tomson, T.5
White, H.S.6
-
25
-
-
77951297857
-
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy
-
Ben-Menachem E, Gabbai AA, Hufnagel A, Maia J, Almeida L, Soares-da-Silva P. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res. 89(2-3), 278-285 (2010
-
(2010)
Epilepsy Res.
, vol.89
, Issue.2-3
, pp. 278-285
-
-
Ben-Menachem, E.1
Gabbai, A.A.2
Hufnagel, A.3
Maia, J.4
Almeida, L.5
Soares-da-Silva, P.6
-
26
-
-
33847611166
-
Eslicarbazepine acetate: A double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures
-
DOI 10.1111/j.1528-1167.2007.00984.x
-
Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 48(3), 497-504 (2007 (Pubitemid 46365199)
-
(2007)
Epilepsia
, vol.48
, Issue.3
, pp. 497-504
-
-
Elger, C.1
Bialer, M.2
Cramer, J.A.3
Maia, J.4
Almeida, L.5
Soares-Da-Silva, P.6
-
27
-
-
61849168486
-
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group Phase III study
-
BIA-2093-301 Investigators Study Group
-
Elger C, Halász P, Maia J, Almeida L, Soares-da-Silva P; BIA-2093-301 Investigators Study Group. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group Phase III study. Epilepsia 50(3), 454-463 (2009
-
(2009)
Epilepsia
, vol.50
, Issue.3
, pp. 454-463
-
-
Elger, C.1
Halász, P.2
Maia, J.3
Almeida, L.4
Soares-da-Silva, P.5
-
28
-
-
70349972675
-
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures
-
BIA-2093-303 Investigators Study Group
-
Gil-Nagel A, Lopes-Lima J, Almeida L, Maia J, Soares-da-Silva P; BIA-2093-303 Investigators Study Group. Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol. Scand. 120(5), 281-287 (2009
-
(2009)
Acta Neurol. Scand.
, vol.120
, Issue.5
, pp. 281-287
-
-
Gil-Nagel, A.1
Lopes-Lima, J.2
Almeida, L.3
Maia, J.4
Soares-da-Silva, P.5
-
29
-
-
78649248897
-
Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy
-
BIA-2093-301 Study Group
-
Halász P, Cramer JA, Hodoba D et al.; BIA-2093-301 Study Group. Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Epilepsia 51(10), 1963-1969 (2010
-
(2010)
Epilepsia
, vol.51
, Issue.10
, pp. 1963-1969
-
-
Halász, P.1
Cramer, J.A.2
Hodoba, D.3
-
30
-
-
84862832991
-
Eslicarbazepine acetate add-On for drug-Resistant partial epilepsy
-
CD008907
-
Chang XC, Yuan H, Wang Y, Xu HQ, Zheng RY. Eslicarbazepine acetate add-on for drug-resistant partial epilepsy. Cochrane Database Syst. Rev. 12, CD008907 (2011
-
(2011)
Cochrane Database Syst. Rev.
, vol.12
-
-
Chang, X.C.1
Yuan, H.2
Wang, Y.3
Xu, H.Q.4
Zheng, R.Y.5
-
31
-
-
77955578218
-
Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers
-
MiloVan D, Almeida L, Romach MK et al. Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. Epilepsy Behav. 18(4), 366-373 (2010
-
(2010)
Epilepsy Behav.
, vol.18
, Issue.4
, pp. 366-373
-
-
MiloVan, D.1
Almeida, L.2
Romach, M.K.3
-
32
-
-
78650178478
-
Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)
-
Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X). Epilepsy Res. 92(2-3), 89-124 (2010
-
(2010)
Epilepsy Res.
, vol.92
, Issue.2-3
, pp. 89-124
-
-
Bialer, M.1
Johannessen, S.I.2
Levy, R.H.3
Perucca, E.4
Tomson, T.5
White, H.S.6
-
33
-
-
77955452826
-
Adjunctive brivaracetam for refractory partial-Onset seizures: A randomized, controlled trial
-
N01193 Study Group
-
French JA, Costantini C, Brodsky A, von Rosenstiel P; N01193 Study Group. Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial. Neurology 75(6), 519-525 (2010
-
(2010)
Neurology
, vol.75
, Issue.6
, pp. 519-525
-
-
French, J.A.1
Costantini, C.2
Brodsky, A.3
Von Rosenstiel P4
5
-
34
-
-
79951652267
-
Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam
-
Meador KJ, Gevins A, Leese PT, Otoul C, Loring DW. Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam. Epilepsia 52(2), 264-272 (2011
-
(2011)
Epilepsia
, vol.52
, Issue.2
, pp. 264-272
-
-
Meador, K.J.1
Gevins, A.2
Leese, P.T.3
Otoul, C.4
Loring, D.W.5
-
35
-
-
84155186559
-
Tolerability and safety of perampanel: Two randomized dose-escalation studies
-
Krauss GL, Bar M, Biton V et al. Tolerability and safety of perampanel: two randomized dose-escalation studies. Acta Neurol. Scand. 125(1), 8-15 (2012
-
(2012)
Acta Neurol. Scand.
, vol.125
, Issue.1
, pp. 8-15
-
-
Krauss, G.L.1
Bar, M.2
Biton, V.3
-
36
-
-
17044396861
-
AMPA receptor stimulation mediates the antidepressant-Like effect of a group II metabotropic glutamate receptor antagonist
-
Karasawa J, Shimazaki T, Kawashima N, Chaki S. AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist. Brain Res. 1042(1), 92-98 (2005
-
(2005)
Brain Res.
, vol.1042
, Issue.1
, pp. 92-98
-
-
Karasawa, J.1
Shimazaki, T.2
Kawashima, N.3
Chaki, S.4
-
37
-
-
35348856414
-
Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats
-
DOI 10.1016/j.ejphar.2007.08.006, PII S0014299907008965
-
Shimazaki T, Kaku A, Chaki S. Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats. Eur. J. Pharmacol. 575(1-3), 94-97 (2007 (Pubitemid 47576076)
-
(2007)
European Journal of Pharmacology
, vol.575
, Issue.1-3
, pp. 94-97
-
-
Shimazaki, T.1
Kaku, A.2
Chaki, S.3
-
38
-
-
0022483382
-
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
-
Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232(4753), 1004-1007 (1986 (Pubitemid 16085410)
-
(1986)
Science
, vol.232
, Issue.4753
, pp. 1004-1007
-
-
Majewska, M.D.1
Harrison, N.L.2
Schwartz, R.D.3
-
39
-
-
34250359480
-
Inhibition of evoked glutamate release by neurosteroid allopregnanolone via inhibition of l-type calcium channels in rat medial prefrontal cortex
-
Hu AQ, Wang ZM, Lan DM et al. Inhibition of evoked glutamate release by neurosteroid allopregnanolone via inhibition of l-type calcium channels in rat medial prefrontal cortex. Neuropsychopharmacology 32(7), 1477-1489 (2007)
-
(2007)
Neuropsychopharmacology
, vol.32
, Issue.7
, pp. 1477-1489
-
-
Hu, A.Q.1
Wang, Z.M.2
Lan, D.M.3
|